Influence of comorbid pathology and age on the duration of inpatient treatment in adult patients with respiratory synctyl virus infection
https://doi.org/10.22625/2072-6732-2025-17-2-64-72
Abstract
Purpose of the study. To analyze the influence of comorbid pathology and age on the duration of inpatient treatment of adult patients with respiratory syncytial virus infection.
Materials and methods. An observational retrospective cross-sectional study was conducted of 3821 patients who were treated at the St. Petersburg State Budgetary Institution “Clinical Infectious Diseases Hospital named after. S.P. Botkin” with the main diagnosis B97.4 “Respiratory syncytial virus infection” for the period from January to December 20023. The influence of comorbid pathology and patient age on the duration of hospitalization was analyzed.
Results. A significant increase in the length of hospitalization in patients with respiratory syncytial virus was observed when combined with the following comorbid conditions: J12 “Viral pneumonia, not elsewhere classified”; J15 “Bacterial pneumonia, not elsewhere classified”; G40 “Epilepsy”; K75 “Other inflammatory diseases of the liver”; G62 “Other polyneuropathies”; B27 “Infectious mononucleosis.” In all cases p < 0.001. A relationship was found between the duration of hospitalization and the age of the patients – an increase in age by 2.718 times was accompanied by an increase in the duration of hospitalization by 10.60%.
Conclusion. The results obtained indicate age and comorbid pathology as significant predictors of increasing the duration of hospital treatment for respiratory syncytial infection.
About the Authors
I. I. TokinRussian Federation
Saint-Petersburg
M. V. Klur
Russian Federation
Saint-Petersburg
V. V. Tsvetkov
Russian Federation
Saint-Petersburg
N. R. Davtyan
Russian Federation
Saint-Petersburg
A. V. Kholin
Russian Federation
Saint-Petersburg
M. N. Pogromskaya
Russian Federation
Saint-Petersburg
References
1. Bezuglaya, E. A. Kharakteristika etiologicheskoy struktury i klinicheskogo techeniya ostrykh respiratornykh virusnykh infektsiy v Sankt-Peterburge za 2020-2021 gg [Characteristics of the etiological structure and clinical course of acute respiratory viral infections in St. Petersburg in 2020-2021] / E. A. Bezuglaya // Dni nauki i innovatsiy NovGU : sbornik statey studentov I molodykh uchenykh. V 4 ch. – Velikiy Novgorod: Novgorodskiy gosudarstvennyy universitet imeni Yaroslava Mudrogo, 2023. – Ch. 1. – S. 13-18. – EDN EDRIVU. (In Russian)
2. Denisova, A. R., Maksimov, M. L. Ostryye respiratornyye virusnyye infektsii: etiologiya, diagnostika, sovremennyy vzglyad na lecheniye [Acute respiratory viral infections: etiology, diagnosis, a modern view on treatment] / A. R. Denisova, M. L. Maksimov // Russkiy meditsinskiy zhurnal. Meditsinskoye obozreniye. – 2018. – T. 2, No. 1-2. – S. 99-103. (In Russian)
3. Informatsionnoye pis’mo glavnogo vneshtatnogo spetsialista MZ RF po infektsionnym boleznyam u detey Lobzina Yu. V. po profilaktike RS-infektsii u detey [Information letter from the chief freelance specialist of the Ministry of Health of the Russian Federation on infectious diseases in children Lobzin Yu. V. on the prevention of RS infection in children]. – URL: http://niidi.ru/news/informatsionnoe-pis-mo-glavnogo-vneshtatnogospetsialista-mz-rf-po-infektionnym-boleznym-u-detey-lobzinayu-v-po-profi/ (accessed: 20.04.2022). (In Russian)
4. Klinicheskiye rekomendatsii. Ostryye respiratornyye virusnyye infektsii (ORVI) u vzroslykh [Clinical guidelines. Acute respiratory viral infections (ARVI) in adults] / Nekommercheskoye partnerstvo “Natsional’noye nauchnoye obshchestvo infektsionistov”, Obshcherossiyskaya obshchestvennaya organizatsiya “Rossiyskoye nauchnoye meditsinskoye obshchestvo terapevtov”. – 2021. – ID: 724. – URL: https://cr.minzdrav.gov.ru/schema/724_1 (accessed: 01.12.2022). (In Russian)
5. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiyskoy Federatsii v 2021 godu: gosudarstvennyy doklad [On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2021: state report]. – Moskva: Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebiteley i blagopoluchiya cheloveka, 2022. – 340 p. (In Russian)
6. Ostraya respiratornaya virusnaya infektsiya (ORVI): klinicheskiye rekomendatsii [Acute respiratory viral infection (ARVI): clinical guidelines] / A. A. Baranov, L. S. NamazovaBaranova, Yu. V. Lobzin [et al.] ; Soyuz pediatrov Rossii. – Moskva: Ministerstvo zdravookhraneniya Rossiyskoy Federatsii, 2021. – 42 p. – EDN CNLHRT. (In Russian)
7. Karpova, L. S. Rasprostranennost’ RS-virusnoy infektsii i drugikh ORVI ne grippoznoy etiologii u detey i vzroslykh v regionakh Rossii v 2014-2016 godakh [Prevalence of RS-virus infection and other ARVI of non-influenza etiology in children and adults in the regions of Russia in 2014-2016] / L. S. Karpova, Ye. A. Smorodintseva, T. I. Sysoyeva [et al.] // Epidemiologiya i vaktsinoprofilaktika. – 2018. – T. 17, No. 2(99). – S. 16-26. – DOI 10.24411/2073-3046-2018-10002. – EDN XNSXBJ. (In Russian)
8. Pshenichnaya, N. Yu. Respiratorno-sintsitial’naya infektsiya – sovremennoye sostoyaniye problemy [Respiratory syncytial infection – the current state of the problem] / N. Yu. Pshenichnaya, A. F. Popov, G. V. Gopatsa [et al.] // Infektsionnyye bolezni. – 2023. – T. 21, No. 3. – S. 95-101. – DOI 10.20953/1729-9225-2023-3-95-101. – EDN ITPAPX. (In Russian)
9. Alfano, F. Respiratory Syncytial Virus Infection in Older Adults: An Update / F. Alfano [et al.] // Drugs & Aging. – 2024. – P. 1-19. – DOI: 10.1007/s40266-024-01118-9.
10. Finns, E. Influenza and respiratory syncytial virus during the COVID-19 pandemic: Time for a new paradigm? / E. Finns [et al.] // Pediatr Pulmonol. – 2022. – Vol. 57, No. 1. – P. 38-42. – DOI: 10.1002/ppul.25719.
11. Jackson, M. L. Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older – Washington State, 2011/2012–2015/2016 / M. L. Jackson [et al.] // J Infect Dis. – 2021. – Vol. 223. – P. 147–156. – DOI: 10.1093/infdis/jiaa331.
12. Klimova, L. G. Analiz zabolevayemosti ORVI sredi naseleniya Kurskoy oblasti za period 2012-2021 godov [Analysis of the incidence of ARVI among the population of the Kursk region for the period 2012-2021] / L. G. Klimova, S. V. Gunov, A. V. Vystavkina, S. A. Yakovlev // Integrativnyye tendentsii v meditsine i obrazovanii. – 2022. – T. 4. – S. 147-153. – EDN FJNWNQ. (In Russian)
13. Zhumanova, L. A. Issledovaniye epidemiologicheskoy dinamiki ORVI za posledniye desyat’ let [Study of the epidemiological dynamics of ARVI over the past ten years] / L. A. Zhumanova, M. Yu. Khantturayeva // Ekonomika i sotsium. – 2024. – No. 3-1(118). – S. 631-634. – EDN METJGM. (In Russian)
14. Khunafina, D. Kh. Zabolevayemost’ ORVI i grippom za 2019 god po dannym GBUZ RB IKB No. 4 [The incidence of ARVI and influenza for 2019 according to the State Budgetary Healthcare Institution of the Republic of Bashkortostan IKB No. 4] / D. Kh. Khunafina, G. S. Rakhmatullina, O. A. Asadullina, G. M. Khasanova // Fundamental’nyye i prikladnyye aspekty immunologii, genetiki i infektsiologii : sbornik nauchnykh statey uchastnikov Mezhdunarodnoy nauchno-prakticheskoy konferentsii, Ufa, 13–14 noyabrya 2020 goda. – Ufa : Izdatel’stvo “Sotsial’no-gumanitarnoye znaniye”, 2020. – S. 155-163. – EDN VROOHZ. (In Russian)
15. Mamoshina, M. V. Analiz rezul’tatov monitoringa vozbuditeley ORVI, grippa i COVID-19 u bessimptomnykh lits [Analysis of the results of monitoring of pathogens of ARVI, influenza and COVID-19 in asymptomatic individuals] / M. V. Mamoshina, S. B. Yatsyshina, V. G. Akimkin // Epidemiologiya i infektsionnyye bolezni. Aktual’nyye voprosy. – 2023. – T. 13, No. 2. – S. 63-69. – DOI 10.18565/epidem.2023.13.2.63-9. – EDN INICHD. (In Russian)
16. Nuridinova, Zh. N. Analiz zabolevayemosti grippa, ORVI i corona-virusnoy infektsii v Kyrgyzskoy respublike [Analysis of the incidence of influenza, ARVI and corona-viral infection in the Kyrgyz Republic] / Zh. N. Nuridinova, Z. Sh. Nurmatov // Alatoo Academic Studies. – 2023. – No. 3. – S. 481-489. – DOI 10.17015/aas.2023.233.48. – EDN URLWUR. (In Russian)
17. Grinchenkov, D. V. Obzor i analiz matematicheskikh metodov prognozirovaniya epidemiologicheskogo protsessa na primere grippa i ORVI [Review and analysis of mathematical methods for forecasting the epidemiological process using the example of influenza and ARVI] / D. V. Grinchenkov, D. N. Kushchiy, I. A. Spiridonova, N. I. Khimichev // Vestnik molodozhnoy nauki Rossii. – 2019. – No. 4. – S. 36. – EDN ZGXHKP. (In Russian)
18. Mal’chikov, I. A. Proyavleniye epidemicheskogo protsessa grippa i ORVI v Sverdlovskoy oblasti v sezony 2016-2019 gg [Manifestation of the epidemic process of influenza and ARVI in the Sverdlovsk region in the seasons 2016-2019] / I. A. Mal’chikov, S. V. Koltunov, A. V. Slobodenyuk [et al.] // Vestnik Ural’skoy meditsinskoy akademicheskoy nauki. – 2019. – T. 16, No. 4. – S. 457-464. – DOI 10.22138/2500-0918-2019-16-4-457-464. (In Russian)
19. Smirnov, V. S. Biologiya vozbuditeley i kontrol’ grippa I ORVI [Biology of pathogens and control of influenza and ARVI] / V. S. Smirnov, V. V. Zarubayev, S. V. Petlenko. – Sankt-Peterburg: Gippokrat, 2020. – 336 p. – ISBN 978-5-8232-0643-3. – EDN WSTEXE. (In Russian)
20. Yalalov, A. A. Sovremennyye epidemiologicheskiye osobennosti гриппа i ORVI na territorii Astrakhanskoy oblasti v 2017-2023 gg [Modern epidemiological features of influenza and ARVI in the Astrakhan region in 2017-2023] / A.A. Yalalov, M. V. Kuzmenkov, A. Ye. Spirenkova [et al.] // Mezhdunarodnyy nauchno-issledovatel’skiy zhurnal. – 2024. – No. 7(145). – DOI 10.60797/IRJ.2024.145.186. – EDN XJVNZU. (In Russian)
21. Nam, H. H. Respiratory syncytial virus infection in adults / H. H. Nam, M. G. Ison // BMJ. – 2019. – Vol. 10(366). – P. l5021.
22. Mal’, G. S. Rol’ pleyotropnykh effektov statinov pri korriksii lipidnogo statusa u bol’nykh ishemicheskoy bolezn’yu serdtsa v usloviyakh ORVI [The role of pleiotropic effects of statins in correcting lipid status in patients with coronary heart disease in conditions of ARVI] / G. S. Mal’, M. V. Arefina, I. A. Dorodnykh // Vyzovy vremeni i vedushchiye mirovyye nauchnyye tsentry: sbornik statey po itogam Mezhdunarodnoy nauchno-prakticheskoy konferentsii, Tyumen’, 03 oktyabrya 2018 goda. – Tyumen’ : Obshchestvo s ogranichennoy otvetstvennost’yu “Agentstvo mezhdunarodnykh issledovaniy”, 2018. – S. 13-16. – EDN XZVJRB. (In Russian)
23. Yeraliyeva, L. T. Respiratorno-sintsitial’naya infektsiya v Respublike Kazakhstan [Respiratory syncytial infection in the Republic of Kazakhstan] / L. T. Yeraliyeva, A. M. Kuatbayeva, M. A. Smagul [et al.] // Farmatsiya Kazakhstana. – 2024. – No. 1. – S. 63-69. – DOI 10.53511/pharmkaz.2024.43.88.008. – EDN VHOSRJ.
24. Troeger, C. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 / C. Troeger [et al.] // Lancet Infect Dis. – 2018. – Vol. 18. – P. 1191–1210. – DOI: 10.1016/S1473-3099(18)30310-4.
25. Shi, T. Disease burden estimates of respiratory syncytial virus related acute respiratory infections in adults with comorbidity: a sys- tematic review and meta-analysis / T. Shi [et al.] // J Infect Dis. – 2022. – Vol. 226, Suppl 1. – P. S17–21.
26. Osei-Yeboah, R. Respiratory Syncytial Virus-Associated Hospitalization in Adults with Comorbidities in 2 European Countries: A Modeling Study / R. Osei-Yeboah [et al.] // J Infect Dis. – 2024. – Vol. 229, Supplement_1. – P. S70-S77. – DOI: 10.1093/infdis/jiad510.
27. Sitnikov, I. G. Lecheniye гриппа i drugikh ORVI u bol’nykh сахарным diabetom [Treatment of influenza and other ARVI in patients with сахарным diabetes] / I.G. Sitnikov, V.Kh. Fazylov, Ye.V. Silina // Terapevticheskiy arkhiv. – 2019. – T. 91, No. 10. – S. 39-47. – DOI 10.26442/00403660.2019.10.000333. – EDN UWPMVA. (In Russian)
Review
For citations:
Tokin I.I., Klur M.V., Tsvetkov V.V., Davtyan N.R., Kholin A.V., Pogromskaya M.N. Influence of comorbid pathology and age on the duration of inpatient treatment in adult patients with respiratory synctyl virus infection. Journal Infectology. 2025;17(2):64-72. (In Russ.) https://doi.org/10.22625/2072-6732-2025-17-2-64-72